{"resourceType":"Parameters","parameter":[{"name":"evaluation","resource":{"resourceType":"ImmunizationEvaluation","id":"2018-0016-dose1-evaluation","status":"completed","patient":{"reference":"Patient/2018-0016"},"date":"2020-06-29T00:00:00.000","targetDisease":{},"immunizationEvent":{"reference":"Immunization/2018-0016-dose1"},"doseStatus":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/immunization-evaluation-dose-status","code":"Valid","display":"Valid"}]},"doseStatusReason":[{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/StatusReason","display":""}]}]}},{"name":"evaluation","resource":{"resourceType":"ImmunizationEvaluation","id":"2018-0016-dose2-evaluation","status":"completed","patient":{"reference":"Patient/2018-0016"},"date":"2020-06-29T00:00:00.000","targetDisease":{},"immunizationEvent":{"reference":"Immunization/2018-0016-dose2"},"doseStatus":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/immunization-evaluation-dose-status","code":"Valid","display":"Valid"}]},"doseStatusReason":[{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/StatusReason","display":""}]}]}},{"name":"recommendation","resource":{"resourceType":"ImmunizationRecommendation","patient":{"reference":"Patient/2018-0016"},"date":"2020-06-29T00:00:00.000","recommendation":[{"targetDisease":{"coding":[{"system":"http//snomed.info/sct","code":"66071002","display":"Type B viral hepatitis"}]},"forecastStatus":{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/ForecastStatus","code":"complete","display":"Complete"}]},"description":"Evaluation_Test_Type: All Valid: Forecast Test\nForecast_Test_Type: EvaluationNot recommended: series complete\nGeneral_Description: This test case describes that when a patient is administered the second dose of the Hep B (Heplisav) vaccine at 4 weeks that the dose is considered to be valid, and the series is Complete.","series":"VaccineGroupName.hepB"}]}}]}